Pluto Bioinformatics

GSE92910: Gene expression profiling of histone deacetylase inhibition in triple-negative breast cancer

Bulk RNA sequencing

Analysis of changes in gene expression levels after after prolonged exposure of triple-negative breast cancer cell lines to low doses of Panobinostat (LBH589), a pan-histone deacetylase inhibitor. SOURCE: Dave Hoon John Wayne Cancer Institute